Platinum rechallenge in the era of immune checkpoint inhibitor in locally advanced/metastatic urothelial carcinoma: Multicenter retrospective study

被引：0
|
作者：
Kim, E. [1 ]
Kim, J. H. [2 ]
Chu, J. [3 ]
Lee, Y-G. [1 ]
Im, H-S. [4 ]
机构：
[1] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Hematol & Oncol, Sch Med, Seoul, South Korea
[2] Korea Univ, Anam Hosp, Dept Oncol Hematol, Seoul, South Korea
[3] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Pathol, Sch Med, Seoul, South Korea
[4] Ulsan Univ Hosp, Dept Hematol & Oncol, Ulsan, South Korea
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2384P
引用
收藏
页码：S1214 / S1214
页数：1
相关论文
共 50 条
  • [31] Comparative Effectiveness of Immune Checkpoint Inhibitors in Patients with Platinum Refractory Advanced Urothelial Carcinoma
    Swami, Umang
    Haaland, Benjamin
    Kessel, Adam
    Nussenzveig, Roberto
    Maughan, Benjamin Louis
    Esther, John
    Sirohi, Deepika
    Pal, Sumanta K.
    Grivas, Petros
    Agarwal, Neeraj
    JOURNAL OF UROLOGY, 2021, 205 (03): : 709 - 717
  • [32] Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study
    Feng, Jia
    Chen, Xinyi
    Wei, Jiayan
    Weng, Yiming
    Wang, Jingsong
    Wang, Tong
    Song, Qibin
    Min, Peng
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [33] Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study
    Jia Feng
    Xinyi Chen
    Jiayan Wei
    Yiming Weng
    Jingsong Wang
    Tong Wang
    Qibin Song
    Peng Min
    Scientific Reports, 14
  • [34] Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study
    Javier Munárriz
    Gaspar Reynés
    Luisa Sánchez-Lorenzo
    Emilio Esteban
    Laura Basterretxea
    Leticia de Avila-Lizárraga
    Miguel Angel Climent
    María José Juan-Fita
    Corina Escoín
    Javier Puente
    Javier Cassinello
    Sergio Vázquez
    Isabel Chirivella
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 781 - 789
  • [35] Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study
    Munarriz, Javier
    Reynes, Gaspar
    Sanchez-Lorenzo, Luisa
    Esteban, Emilio
    Basterretxea, Laura
    de Avila-Lizarraga, Leticia
    Angel Climent, Miguel
    Jose Juan-Fita, Maria
    Escoin, Corina
    Puente, Javier
    Cassinello, Javier
    Vazquez, Sergio
    Chirivella, Isabel
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (04) : 781 - 789
  • [36] Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study
    Varadi, Melinda
    Horvath, Orsolya
    Modos, Orsolya
    Fazekas, Tamas
    Grunewald, Camilla M.
    Niegisch, Guenter
    Krafft, Ulrich
    Gruenwald, Viktor
    Hadaschik, Boris
    Olah, Csilla
    Maraz, Aniko
    Furka, Andrea
    Szucs, Miklos
    Nyirady, Peter
    Szarvas, Tibor
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [37] Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study
    Melinda Váradi
    Orsolya Horváth
    Orsolya Módos
    Tamás Fazekas
    Camilla M. Grunewald
    Günter Niegisch
    Ulrich Krafft
    Viktor Grünwald
    Boris Hadaschik
    Csilla Olah
    Anikó Maráz
    Andrea Furka
    Miklós Szűcs
    Péter Nyirády
    Tibor Szarvas
    Scientific Reports, 13
  • [38] Clinical efficacy of combination therapy of an immune checkpoint inhibitor with taxane plus platinum versus an immune checkpoint inhibitor with fluorouracil plus platinum in the first-line treatment of patients with locally advanced, metastatic, or recurrent esophageal squamous cell carcinoma
    Li, Ying
    Ji, Yanyan
    Shen, Lin
    Yin, Xudong
    Huang, Tianyu
    Deng, Bin
    Guo, Hong
    Wu, Yunjiang
    Chen, Yong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [39] Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease
    Wong, Risa L.
    Ferris, Lorin A.
    Do, Olivia A.
    Holt, Sarah K.
    Ramos, Jorge D.
    Crabb, Simon J.
    Sternberg, Cora N.
    Bellmunt, Joaquim
    Ladoire, Sylvain
    De Giorgi, Ugo
    Harshman, Lauren C.
    Vaishampayan, Ulka N.
    Necchi, Andrea
    Srinivas, Sandy
    Pal, Sumanta K.
    Niegisch, Guenter
    Dorff, Tanya B.
    Galsky, Matthew D.
    Yu, Evan Y.
    ONCOLOGIST, 2021, : 1026 - 1034
  • [40] Safety and efficacy of enfortumab vedotin for locally advanced or metastatic urothelial carcinoma in patients aged 80 years and older: A multicenter retrospective study in Japan
    Kobari, Yuki
    Iizuka, Junpei
    Kondo, Hanae
    Ichioka, Makiko
    Watanabe, Shun
    Nakamura, Kazutaka
    Horiuchi, Toshihide
    Mizoguchi, Shinsuke
    Yoshida, Kazuhiko
    Shimmura, Hiroaki
    Hashimoto, Yasunobu
    Kondo, Tsunenori
    Kobayashi, Hiroshi
    Takagi, Toshio
    JOURNAL OF GERIATRIC ONCOLOGY, 2025, 16 (03)
12345